HealthEquity Q4 2020 Earnings Report
Key Takeaways
HealthEquity reported a revenue of $201.2 million, a 166% increase compared to Q4 FY19. The company reported a net loss of $0.2 million, and non-GAAP net income of $27.9 million. Total HSAs exceeded 5.3 million, an increase of 34% year over year.
Revenue increased by 166% to $201.2 million compared to Q4 FY19.
Net loss was $0.2 million, compared to net income of $13.1 million in Q4 FY19.
Non-GAAP net income was $27.9 million, compared to $18.9 million in Q4 FY19.
Adjusted EBITDA increased by 125% to $61.3 million compared to $27.3 million in Q4 FY19.
HealthEquity
HealthEquity
HealthEquity Revenue by Segment
Forward Guidance
For the fiscal year ending January 31, 2021, HealthEquity expects revenue between $770 million and $790 million. Net loss is projected in the range of $14 million to $4 million, with an adjusted EBITDA outlook between $245 million and $255 million.
Positive Outlook
- Revenue to be between $770 million and $790 million.
- Adjusted EBITDA outlook is a range of $245 million to $255 million.
- Non-GAAP net income between $124 million and $132 million.
- Non-GAAP net income per diluted share range between $1.70 and $1.81.
- Momentum in HSA growth, taking a larger share of the market than ever before.
Challenges Ahead
- Net loss is projected in the range of $14 million to $4 million.
- Net loss per diluted share range of $0.19 to $0.05.
- Uncertain healthcare environment.
- Potential future cybersecurity breaches.
- Ability to realize the anticipated financial and other benefits from combining the operations of WageWorks with our business in an efficient and effective manner.
Revenue & Expenses
Visualization of income flow from segment revenue to net income